bioRxiv preprint doi: https://doi.org/10.1101/819649; this version posted October 28, 2019. The copyright holder for this preprint (which was not
certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under
aCC-BY 4.0 International license.

MAUDE: Inferring expression changes in sorting-based
CRISPR screens
Carl G. de Boer1,2,Â§, John P. Ray1, Nir Hacohen1,3, and Aviv Regev1,2,4,5Â§
1

Broad Institute of MIT and Harvard University, Cambridge, MA 02142, USA

2

Klarman Cell Observatory, Broad Institute of MIT and Harvard University, Cambridge,
MA 02142, USA
3

Center for Cancer Research, Massachusetts General Hospital, Boston, MA 02114, USA

4

Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02142,
USA
5

Howard Hughes Medical Institute, Cambridge, MA 02142

Â§

correspondence should be addressed to CGD (carlgdeboer@gmail.com) and AR
(aregev@broadinstitute.org)

1

bioRxiv preprint doi: https://doi.org/10.1101/819649; this version posted October 28, 2019. The copyright holder for this preprint (which was not
certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under
aCC-BY 4.0 International license.

Abstract
Pooled CRISPR screens allow high-throughput interrogation of genetic elements that
alter expression of a reporter gene readout. New computational methods are needed to
model these data. We created MAUDE (Mean Alterations Using Discrete Expression) for
quantifying the impact of guide RNAs on a target geneâ€™s expression in a pooled, sortingbased expression screen. MAUDE quantifies guide-level effects by modeling the
distribution of cells across sorting expression bins. It then combines guides to estimate
the statistical significance and effect size of targeted genetic elements. We show that
MAUDE significantly improves over previous approaches and provide experimental
design guidelines to best leverage MAUDE.

2

bioRxiv preprint doi: https://doi.org/10.1101/819649; this version posted October 28, 2019. The copyright holder for this preprint (which was not
certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under
aCC-BY 4.0 International license.

Background
Pooled CRISPR/Cas9 screens with a readout of reporter geneâ€™s expression have
improved our understanding of how both cis and trans regulators control gene
expression. CRISPR/Cas9 and related systems use complementarity between an RNA
guide and the genomic DNA to direct Cas9 to specific loci. Engineered Cas9 proteins
with different enzymatic and regulatory activities now allow researchers to mutate DNA1,
modify the chromatin state2 of the targeted locus, inertly bind loci to inhibit
transcription3, or recruit activators4. Using these tools, pooled screens with libraries of
guides targeting genes or the non-coding genome and measuring the impact on a reporter
geneâ€™s expression can identify trans regulators or cis-regulatory elements that affect the
reporterâ€™s expression1, 2, 5-7. For instance, CRISPR interference (CRISPRi) and CRISPR
activation (CRISPRa) have been used to respectively repress or activate elements in a
targeted cis-regulatory region and identify enhancers of a geneâ€™s expression2, 4, 8, 9. In
each case, we estimate how each guide affects the targeted (or reporter) geneâ€™s expression
by sorting cells into discrete expression bins, and measuring the guideâ€™s abundance in the
bins. Such screens help dissect enhancer regulatory logic5, 8, and identify the genetic
variation most likely to contribute to common human disease9.
Despite the growing number of gene expression CRISPR screening strategies,
computational methods to determine which guides and elements alter gene expression
remain relatively ad hoc. In general, detecting guides that impact expression relies on
finding those with a biased distribution across the expression bins. To date, most methods
fall into two categories: (1) using the log fold-change between the guide abundances in
the high and low expression bins directly5, 6, 9, or (2) repurposing RNA-seq differential
expression tools10, 11 to find changes in guide abundance between high and low bins6, 12.
However, both strategies are difficult to apply if more than two sorting bins are used and
do not leverage the unique character of these data.
Here, we describe MAUDE (Mean Alterations Using Discrete Expression), an analytical
framework for estimating the effect of CRISPR guides (or other perturbagens) on
expression, as measured by sorting into discrete expression bins and sequencing.
MAUDE maximizes the likelihood of the observed sequencing data over the cell sorting
bins to estimate the mean expression for cells containing each guide. It then combines the
resulting Z-scores from multiple guides targeting the same element into element-level
effect sizes and estimates statistical significance. Elements can defined a priori, by
annotating guides with the element they target, or identified de novo by using a sliding
window to combine guides targeting neighboring chromosomal locations. MAUDE is
highly sensitive at finding expression-altering guides and elements, is adept at estimating
effect sizes, and outperforms existing approaches. Finally, we provide guidance on the
design of expression-based CRISPR screens to maximize the information gleaned.

Results
MAUDE identifies expression-altering guides by their distribution across bins
To identify guides that alter expression, MAUDE makes four assumptions: (1) the
perturbations do not differentially affect cell viability; (2) expression is distributed
approximately (log) normally; (3) guides can alter the mean expression, but not the
3

bioRxiv preprint doi: https://doi.org/10.1101/819649; this version posted October 28, 2019. The copyright holder for this preprint (which was not
certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under
aCC-BY 4.0 International license.

variance; and (4) sampling by sequencing of CRISPR guides integrated in the genomic
DNA of sorted cells is captured by a negative binomial distribution (as described
previously10, 13, 14). Note that when assumptions (2) or (3) are violated, such as if
expression is bimodal (e.g. perturbations alter the fraction of expressing cells), MAUDE
guide-level effect sizes correspond to the average effect of the perturbation (see below).
Additionally, we require that the bin sizes be known (as a fraction of the total expression
distribution of sorted cells), that the unsorted input library be sequenced to quantify
overall library composition, and that the screen includes non-targeting control guides that
should not affect expression.

Figure 1: MAUDE approach to scoring expression-based screens (A) Method overview. (BD) MAUDE approach to estimating the optimal mean expression level per guide. (B) Estimation
of cell density distribution for each guide. Cell density distribution (y axis) of target gene
expression (x axis) for each guide is modeled as a normal distribution, with mean Âµg. Âµg is
optimized by calculating, for each bin (Bin A and B, top), the fraction of cells expected to be in
the bin under the null model (no overall change in expression; ğ‘†(ğ‘, 0)) and the fraction of cells
expected in the bin given the current value of Âµg (ğ‘†(ğ‘, ğœ‡! )). (C) Estimation of optimal Âµg. We find
the optimal ğœ‡! by calculating the log likelihood (y axis) of the observed bin read abundances
given each value of Âµg (x axis). (D) Expected number of guide reads per bin. The fraction of reads
(y axis) of guide g (ğ‘ƒ! ğ‘” ğœ‡! ) expected in each bin b (x axis), for different values of Âµg (colors).

MAUDE estimates the most likely mean expression level effect of a given guide g, ğœ‡! ,
by maximizing the likelihood of the observed reads per bin under these assumptions (Fig.
1). To do so, it estimates the number of reads of guide g expected to be in each
expression bin b, for a given mean expression level Âµg. It estimates the optimal ğœ‡! as the
one that maximizes the log likelihood of the observed number of reads given the expected
number of reads in each bin (Fig. 1A - left).
4

bioRxiv preprint doi: https://doi.org/10.1101/819649; this version posted October 28, 2019. The copyright holder for this preprint (which was not
certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under
aCC-BY 4.0 International license.

To achieve this, MAUDE proceeds in several steps. First, it uses the unsorted (input)
library to estimate the library composition, defined as ğ‘Ÿâˆ…! /ğ‘…âˆ… , the fraction of reads from
guide g (ğ‘Ÿâˆ…! ) out of the total reads (ğ‘…âˆ… ). Next, using the overall fraction of cells observed
in each expression bin (recorded during cell sorting), it quantile normalizes the sorting
expression space to a standard normal reference (Âµ=0 and Ïƒ=1). For each bin, it calculates
the Z-scores in standard normal space (Zb0 and Zb1 for lower and upper limit, respectively)
that capture the same quantile as the bin captured in the original (FACS) data. Since most
guides in such screens do not alter expression, the vast majority of the overall distribution
represents the expression Ïƒ associated with no effect (e.g. wild type). Thus, for modeling
simplicity, we can assume that each guide has the same Ïƒ â€“ that of the overall
distribution. It then defines S(b, Âµg) as the fraction of cells containing guide g expected by
the model to have been sorted into bin b (with the bin defined by Zb0 and Zb1,
respectively). S(b, Âµg) is calculated using the normal cumulative distribution function,
CDFnorm(), yielding the probability that a cell sampled from a normal distribution with
mean Âµg will have an expression (x) less than the sorting upper bin bound Zb1, but not
smaller than the lower bin bound Zb0:
ğ‘† ğ‘, ğœ‡! = ğ¶ğ·ğ¹!"#$ ğ‘¥ + ğœ‡! â‰¤ ğ‘!! âˆ’ ğ¶ğ·ğ¹!"#$ (ğ‘¥ + ğœ‡! â‰¤ ğ‘!! )

(1)

For a given Âµg, MAUDE calculates the expected expression distribution (Fig. 1B). The
expected fraction of cells in bin b that contain guide g is:
ğ‘ƒ! ğ‘” ğœ‡! =

!âˆ…!
!âˆ…

Ã—

!(!,!! )
!(!,!)

(2)

Intuitively, if guide g does not affect expression, Âµg is 0, and so ğ‘ƒ! (ğ‘”|ğœ‡! ) is just the
fraction of the overall library occupied by the guide (ğ‘Ÿâˆ…! /ğ‘…âˆ… ); if the value of Âµg results in
a higher fraction of cells containing guide g in bin b, the guide is enriched in that bin
(ğ‘ƒ! (ğ‘”|ğœ‡! ) > ğ‘Ÿâˆ…! /ğ‘…âˆ… ; Fig. 1B - right); depletion results when fewer cells end up in the
bin (ğ‘ƒ! ğ‘” ğœ‡! < ğ‘Ÿâˆ…! /ğ‘…âˆ… ; Fig. 1B - left).
Finally, MAUDE learns the optimal Âµg given the observed guide reads, by maximizing
the (log) likelihood of observing the reads from the guide g in each bin b (rgb), given the
overall number of reads observed in that bin (Rb; Fig. 1C,D). To reduce the impact of
cases where a guide cannot be quantified reliably due to low coverage, MAUDE also
includes a prior favoring no change in expression via a pseudocount added uniformly to
all expression bins (Methods). We assume reads are sampled using a negative binomial
distribution (with probability density function PDFNB())10, 13, 14. Thus, MAUDE
maximizes the following equation separately for each guide g to learn its optimal ğœ‡! :
ğœ‡! = argmax!!

!"#$ !

log (ğ‘ƒğ·ğ¹!" ğ‘Ÿ!" , ğ‘…! , ğ‘ƒ! ğ‘” ğœ‡! )

(3)

Once MAUDE learned ğœ‡! for each guide, it subtracts from each the average ğœ‡! of the
non-targeting guides (ğœ‡!" ) to convert each guideâ€™s effect on expression to a Z-score (Zg;
Fig. 1A â€“ middle):
ğ‘! = ğœ‡! âˆ’ ğœ‡!"

(4)

This step is necessary because targeting guides, whose true mean is sometimes not 0, are
also included in the overall distribution and may have shifted the overall mean. Thus, Zg
5

bioRxiv preprint doi: https://doi.org/10.1101/819649; this version posted October 28, 2019. The copyright holder for this preprint (which was not
certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under
aCC-BY 4.0 International license.

represents the number of standard deviations (SDs) by which guide g has altered gene
expression compared to the non-targeting guides.
MAUDE calculates element level effect size and significance by aggregating signal
across guides
With a Z-score representing the expression change for every guide, MAUDE calculates
element-level effect size and statistical significance (Fig. 1A â€“ right), using either (1)
known element annotations or (2) a sliding window across the locus of interest to define
elements. Examples of potential annotated elements are putative enhancers or protein
coding genes. Sliding windows require that the region be tiled with guides, with the final
resolution and sensitivity proportional to the tiling density, but require no prior
knowledge about the region. We combine all guides within a pre-specified window size
(e.g. 500 bp), requiring a minimum number of guides per window (e.g. 5), and testing all
possible windows with distinct guide sets. The elementâ€™s effect size, expressed as a Zscore, is the average Z-score of the guides targeting that element.
To estimate statistical significance, we combine guide-level Z-scores for all guides
targeting that element (by Stoufferâ€™s method) into a single Z-score, representing a signed
significance of the regulatory change (Z>0 representing upregulation, and Z<0
representing downregulation). Because experimental noise and the number of guides per
element can greatly affect the robustness of these Stouffer Z-scores, we repeatedly
sample the non-targeting guides for each experiment and every possible number of
guides/element, to create null distributions. We then scale the Stouffer Z-scores by the
standard deviation of the corresponding null (i.e. the null for that experiment with the
same number of guides/element). Finally, the resulting significance Z-scores are
converted into P-values using the normal cumulative distribution function (Âµ=0, Ïƒ=1), for
the upper tail (upregulation), lower tail (downregulation), or the minimum of the two
(either), with corresponding Benjamini-Hochberg FDR correction.
MAUDE correctly identifies differential elements in simulated data
To test MAUDEâ€™s performance and underlying assumptions, we next simulated two
experiments, each with 200 targeted elements and 5 guides per element. We compared
two ways in which expression might be altered by targeting of an element: (1) a shift
from one unimodal distribution of expression levels to another, reflecting an impact on
expression affecting each perturbed cell (Âµg ranging from 0.01 to 1 SDs, in 0.01
increments; â€œmean-alteringâ€; Fig. 2A); or (2) having two fixed distributions of expression
levels, as would be the case in two sub-populations, with the perturbation causing a shift
in the relative proportion of cells in each expression mode (Âµg = 1; and the fraction of
affected cells rg ranges from 1% to 100%, in 1% increments; â€œproportion-alteringâ€; Fig.
2B). In either case, 100 â€œeffectiveâ€ elements have an impact, and the other 100
â€œineffectiveâ€ elements have no effect on expression. We generated these synthetic data,
simulating sorting cells by expression into six different 10% bins on the extremes of
expression (Methods).
MAUDE analysis was adept at identifying effective elements, and accurately estimated
effect sizes and fractions of responding cells. In both simulations, it detected as
significant (1% Benjamini-Hochberg FDR) 97 of the 100 effective elements, with effect
6

bioRxiv preprint doi: https://doi.org/10.1101/819649; this version posted October 28, 2019. The copyright holder for this preprint (which was not
certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under
aCC-BY 4.0 International license.

sizes as low as 0.03 SDs (mean-altering; Fig. 2C) or 3% of cells responding (proportionaltering; Fig. 2D), indicating that MAUDE is sensitive to even small changes. As
expected, each simulation included 1-2 false positives (2/99 and 1/98 for mean-altering
and proportion-altering simulations, respectively; estimated effect size of ~0.04 SDs for
both), consistent with our 1% FDR, indicating that our P-values are well-calibrated. The
correlation between inferred and actual effect size was very high (Pearsonâ€™s r = ~0.998
for both simulations; only considering the 100 simulation-defined effective elements). In
the proportion-altering simulation, the estimated effect size corresponds to the average
affect size (e.g. 10% of cells shifting by 1 SD results in an average effect size of 0.1).
Overall, MAUDE performs extremely well on synthetic data and can identify
perturbations that shift the mean expression or the fraction of expressing cells with high
sensitivity and specificity.

Figure 2: MAUDE correctly identifies functional elements and effect sizes in simulated data
(A) Simulation for mean-altering elements. A mean altering element is modeled as changing the
mean expression Âµg (between 0.01 and 1) of cells with the effective element (red curve) compared
to cells with ineffective elements or non-targeting guides (gray curve). (B) Simulation of
proportion-altering elements. A proportion-altering element is modeled as resulting in a different
proportion of cells with altered expression (rg), from 1% to 100%. On average, rg% of cells would
have expression increased by Âµg= 1 (dark red curve), and (1-rg)% of cells would have no change
in expression (Âµg = 0; light red curve) relative to ineffective elements and non-targeting guides
(gray curve). (C, D) Effect sizes are correctly estimated. The true effect used to generate the

7

bioRxiv preprint doi: https://doi.org/10.1101/819649; this version posted October 28, 2019. The copyright holder for this preprint (which was not
certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under
aCC-BY 4.0 International license.

simulated data (x axis) versus the inferred effect size (y axis) for (C) mean-altering elements
(where the true effect is Âµg), and (D) proportion-altering elements (where the true effect is rg).
Elements meeting a 1% FDR are shown in red and others in gray. Pearsonâ€™s r is shown in lower
left (considering effective elements only). Black line: y=x.

MAUDE application to a CD69 CRISPRa screen increases accuracy and highlights
new regulatory elements
We next evaluated MAUDEâ€™s performance on actual data from a CRISPRa tiling screen
to identify regions that could regulate CD69 in Jurkat cells9, which was conducted in
duplicate. We compared MAUDE to the original analysis (â€œoriginalâ€), where guide
effects were estimated as the log ratio of normalized counts within the â€œhighâ€ enriched
bin and â€œbaselineâ€ bin9, and with edgeR10 and DESeq211, looking for differential guides
between the â€œhighâ€ and â€œbaselineâ€ bins following previous studies6, 12.
We assessed the sensitivity and accuracy of each approach by three criteria, where
possible: (1) higher similarity between effect sizes of adjacent guides, which are expected
to more often target the same regulatory element, compared to pairs of randomly selected
guides; (2) ability to distinguish promoter-targeting guides from other targeting guides,
because CD69 promoter-targeting guides are a positive control expected to greatly alter
CD69 expression; and (3) similarity between the effect sizes estimated for each replicate,
which should be high if a method is successful.
MAUDE performed well on all three measures, out-performing the other approaches
(Fig. 3A-C). MAUDE most easily distinguished adjacent from randomly paired guides
(by AUROC; Fig. 3A), with adjacent guides having more similar effect sizes than
randomly paired guides, as expected; MAUDE most easily distinguished promotertargeting guides from other genome-targeting guides (by AUROC; Fig. 3B); and the
estimated guide-level effects were much more correlated between the two replicates for
MAUDE than for the original approach (Pearsonâ€™s r = 0.66 vs. 0.25, respectively; edgeR
and DESeq2 do not return replicate-level statistics; Fig. 3C).
We next asked if MAUDE yielded any new insights into CD69 regulation, which were
not highlighted in the original analysis. We generated element-level statistics using a
200 bp sliding window across the locus, combining the two experimental replicates by
requiring elements to have FDR < 0.01 in both replicates and consistent expression
changes. The minimum element effect size that was reproducibly found by MAUDE was
a change of 0.12 SDs.

8

bioRxiv preprint doi: https://doi.org/10.1101/819649; this version posted October 28, 2019. The copyright holder for this preprint (which was not
certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under
aCC-BY 4.0 International license.

Figure 3: MAUDE outperforms other methods and yields insight into CD69 regulation (AC) MAUDE outperforms other methods by three criteria. Comparison of the original analysis of
CD69 CRISPRa tiling screen9 (â€œoriginalâ€), edgeR, DESeq2, and MAUDE (x axes), by three
evaluation criteria (y axes, higher values correspond to better performance): (A) relative
similarity in effect sizes of adjacent guides (compared to randomly selected pairs of guides, by
AUROC); (B) ability to distinguish promoter-targeting guides from other targeting guides; and
(C) Pearson correlation between the effect size estimates of both replicates. Correlation between
replicates was not possible for edgeR or DESeq2 as they combine replicates to estimate effect
sizes and statistics. (D) Reanalysis of CD69 CRISPRa screen data with MAUDEâ€™s sliding
window approach highlights additional plausible regulatory elements. Effect size (y axes) vs
genomic position (x axis) for two replicates (top and bottom), with elements (points) colored by
those that significantly increased (red) or decreased (blue) expression of CD69 and those that did
not (black). Bottom: Gene annotations (blue) and Jurkat DNaseI hypersensitivity (black). Vertical
bars: Clusters of significant elements identified by MAUDE: regions that increase CD69
expression (red), and regions that decrease CD69 expression (blue), with previously identified
regions indicated (gray border).

9

bioRxiv preprint doi: https://doi.org/10.1101/819649; this version posted October 28, 2019. The copyright holder for this preprint (which was not
certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under
aCC-BY 4.0 International license.

MAUDE re-discovered the four regions previously called as being CRISPRa-sensitive
(Fig. 3D, gray bars), and called 15 additional regions as responsive to CRISPRa. Of
these, 10 appeared to cause a down-regulation of CD69 when activated by CRISPRa
(Fig. 3D, red bars). Although none of these are in open chromatin regions in Jurkat cells,
two are adjacent to the promoters of other nearby genes (CLECL1 and CLEC2B),
suggesting these may act by competition with the CD69 promoter. Similar opposing
effects on expression have been previously reported when targeting the promoters of
neighboring genes with CRISPRi8, 12. The remaining five CRISPRa-sensitive regions we
identified caused upregulation of CD69; all five of these regions overlapped with Jurkat
open chromatin regions (Fig. 3D, red bars), as did the CRISPRa-sensitive regions
originally identified9. Overall, 85% of CD69-upregulating elements identified by
MAUDE were within Jurkat open chromatin and were closer to open chromatin than
expected by chance (rank sum P<10-15; distances to open chromatin vs. distances to
randomly-placed open chromatin; Methods).
MAUDE helps design bin number and width to enhance screen sensitivity
While an experimenter can set the sizes of the expression bins, finding an optimal bin
configuration experimentally is laborious and costly, and typically not pursued in
practice. We reasoned that our simulation framework can readily test different expression
bin configurations to help choose the best one under our assumptions.
To this end, we accounted for several experimental considerations. First, cell sorters can
have between two to six bins available, and the optimal bin size may differ when
different numbers of bins are used. Second, the tails of the distribution are the most
informative because they show the greatest ratios of effective versus ineffective guides,
and this ratio increases as bins get more extreme. However, the more extreme the bins,
the fewer cells will be captured, resulting in higher sampling noise. Finally, it is desirable
to have each bin capture approximately the same number of cells to facilitate uniform
treatment of samples (e.g. genomic DNA isolation and library preparation).
With these considerations in mind, we tested by simulation how bin size and number
altered the ability to identify differentially active elements (Fig. 4A). We altered our
simulation framework to include more elements (1,000 ineffective and 1,000 effective),
and, to make the recovery of effective elements more challenging, focused on smaller
effect sizes (100 each with effect sizes from 0.01 to 0.1, at 0.01 increments). Here, the
smallest effect sizes are the most difficult to recover and only the most sensitive
approaches will recover them. Our bin configurations included both uniform percentile
bins and more complex bin configurations, always placing bins symmetrically at both
tails of the distribution, and, within each tail, bins are contiguous (Fig. 4A, right).
Uniform binning schedules were also tested with two and four bins, always retaining the
most extreme bins. Otherwise, six bins were used. We evaluated bin configurations for
their accuracy in predicting effect sizes (Pearsonâ€™s r) and their sensitivity in recovering
functional elements (true positives).

10

bioRxiv preprint doi: https://doi.org/10.1101/819649; this version posted October 28, 2019. The copyright holder for this preprint (which was not
certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under
aCC-BY 4.0 International license.

Figure 4: MAUDE simulations propose optimal cell-sorting bin configurations (A)
Evaluation of expression bin configurations by simulation. Left: An experiment is simulated (10
replicates, top), followed by selection of each bin configuration, MAUDE analysis and evaluation
of performance for true positive recovery and effect size prediction (by Pearsonâ€™s r). Right: Each
bin configuration had 2-6 bins that are contiguous on each end and symmetric about the center,
progressing gradually with inclusion from outer to innermost: A and F: outermost and always
included, B and E (when present): contiguous with A and F (respectively) and more central; and
C and D (when present): contiguous with B and E (respectively) and innermost. (B, C)
Identification of optimal bin configurations. Performance (y axis) of each bin configuration (x
axis) for (B) Pearsonâ€™s r between the true effect sizes (as defined in the simulation) and the
predicted effect sizes (by MAUDE), and (C) the number of true positives (elements defined as
having an effect in the simulation that are predicted to have an effect by the analysis). x axis
labels: Bin sizes expressed as the percent of the distribution covered by each of the paired
corresponding bins, sorted in order of increasing performance. Error bars: standard error of the

11

bioRxiv preprint doi: https://doi.org/10.1101/819649; this version posted October 28, 2019. The copyright holder for this preprint (which was not
certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under
aCC-BY 4.0 International license.

mean (SEM) for the 10 simulated experiments. Gray shading: number of bins in the
configuration.

The best bin configurations include more bins and cover of most of the distribution.
When using non-uniform bins, greater resolution (i.e. smaller bin sizes) at the tails of the
distribution (i.e. A/F scheme, Fig. 4A) resulted in both greater sensitivity and accuracy
than greater resolution at the inner bins (Fig. 4B,C). Having more sorting bins was
always better, but particularly when bins are small, and going from two to four bins was a
much more significant increase than from four to six bins (Fig. 4B,C). Overall,
performance was relatively poor when bins covered less than 20% of the overall
distribution (Fig. 4B,C â€“ indicated at left). However, performance is also poor if bins are
too large, presumably because resolution is reduced. For example, having two 50% bins
was worse than two 25% bins, and four 25% bins was worse than four 12.5% bins (Fig.
4B,C). The best configuration tested by both measures had A and F cover 5%, B and E
cover 10%, and C and D cover 20%, but uniform bins covering 12.5 - 15% had similar
performance (Fig. 4B,C) and yield uniform cell numbers per sample, and so are more
practical. Overall, this simulation indicates that the greatest sensitivity and accuracy is
achieved by having more bins, good performance can be achieved with uniform bins, and
each of the bins should cover about ~15% of the distribution (~25% if using only two
bins).

Discussion
MAUDE is a principled framework for the analysis and design of pooled CRISPR
screens with an expression readout. By estimating the effects of guides and elements
from the distribution of guides across bins, we show that MAUDE is both sensitive and
specific on simulated data, and more accurate on real data, allowing the recovery of
additional regulatory elements. Notably, although our sliding window approach can be
used for identifying regulatory regions in a tiling experiment, MAUDE can also be used
in combination with other approaches15. MAUDEâ€™s simulation framework can help
experimental design to maximize a screenâ€™s success.
Although we focus our testing on CRISPR screens aiming to identify regulatory elements
with a guide RNA perturbagen, which are the current common examples, we expect any
experiment with a binned expression readout and sequencing to quantify perturbations
could use MAUDE analysis. This could include perturbations of genes 6, other types of
perturbagens (e.g. RNAi), direct readouts of mutation (e.g. via base editors), or even
reporter assays16.

Conclusions
MAUDE is a highly sensitive and accurate approach for identifying functional elements
in a binned expression screen. MAUDE estimates the effect size on expression of
individual perturbagens (e.g. CRISPR guide RNAs), and combines perturbagens to
estimate the effects of genetic elements. MAUDE performs well in simulations, and
outperforms other methods on experimental data by all three independent evaluation
criteria. Finally, by simulation, we identify which cell-sorting bin configurations are
optimal.
12

bioRxiv preprint doi: https://doi.org/10.1101/819649; this version posted October 28, 2019. The copyright holder for this preprint (which was not
certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under
aCC-BY 4.0 International license.

As research focused on the function on regulatory variants and regions, which are
disproportionately contributing to the genetic basis of common disease17, we expect that
pooled genetic screens with expression readouts will become much more common.
Moreover, many such variants and elements are expected to have smaller effect sizes,
emphasizing the need for sensitive detection and accurate effect size estimates. We
anticipate that MAUDE â€“ which we implemented as an R package available on GitHub
(https://github.com/Carldeboer/MAUDE) â€“ will become an important tool in the effort to
map from variants to function.

Methods
Implementation and usage
MAUDE is implemented in R. Tutorials are provided on the MAUDE website
(https://github.com/Carldeboer/MAUDE). Users provide a data.frame, with columns
containing the bin counts (one column per bin, plus one for the unsorted cells), as well as
columns annotating the data included in each row, including: guide ID, experimental
identifiers (e.g. replicate, condition, etc.), whether or not the guide is a non-targeting
guide, and any other guide-associated data (e.g. genomic locus). Users also provide a
data.frame containing the bin sizes, with one row per bin per experiment, and columns
corresponding to the Z-score bounds of each bin (â€˜binStartZâ€™ and â€˜binEndZâ€™) and the
corresponding bin cumulative distribution function percentiles (â€˜binStartQâ€™ and
â€˜binEndQâ€™). Using MAUDEâ€™s â€˜findGuideHitsAllScreensâ€™ function, and providing the
experimental design data.frame, read count data.frame, and bin bound data.frame,
MAUDE will calculate the optimal mean expression for each guide, separately for each
experiment, returning the mean guide expression (ğœ‡! ), Z score (Zg), and log likelihood
ratio for each guide/experiment pair. By default, for each guide g and bin b, 10
pseudocounts are added to the read count (rg,b) for every million reads of coverage in that
bin (Rb) to reduce the noise resulting from poor coverage. Râ€™s â€˜optimizeâ€™ function is used
for finding the guide mean expression with the highest log likelihood. The fraction of
cells expected to be in a bin given the current ğœ‡! is calculated with the â€˜pnormâ€™ function,
scaled by the overall abundance in the library of that guide and the fraction of cells sorted
into the bin, as in Equation (2). The log likelihood for each guide/bin is calculated as
using the â€˜dnbinomâ€™ function, with x = number of reads for this guide in this bin, size =
number of reads total for this bin, prob = 1 - the fraction of this bin expected to be
occupied by this guide, as in Equation (3). The â€˜findGuideHitsAllScreensâ€™ will return the
guide-level statistics as a data.frame.
Once guide-level statistics have been calculated for each experiment, they can then be
combined
to
obtain
element-level
statistics.
Using
MAUDEâ€™s
â€˜getTilingElementwiseStatsâ€™ function, one can identify elements de novo by tiling across
the region, providing the experimental design data.frame and the guide-level statistics
data.frame, including columns denoting the genomic coordinates of the guide
(chromosome, position). By default, all guides within each 500 bp window are combined
in this sliding window approach, requiring a minimum of five guides per window
(parameters which can and should be customized, dependent on the density of tiled
guides), and testing all possible windows with unique guide sets. Alternatively, MAUDE
13

bioRxiv preprint doi: https://doi.org/10.1101/819649; this version posted October 28, 2019. The copyright holder for this preprint (which was not
certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under
aCC-BY 4.0 International license.

provides the â€˜getElementwiseStatsâ€™ function to calculate element-level statistics given
element annotations as an additional column in the guide-level statistics data.frame.
In either case, element-level statistics are calculated by combining all Z-scores for guides
in the element. Three Z-scores are calculated for each element: (1) an effect size â€“ the
mean of the guidesâ€™ Z-scores; (2) the Stouffer Z-score â€“ the guidesâ€™ Z-scores combined
with Stoufferâ€™s method (â€˜stoufferZâ€™); and (3) a significance Z-score â€“ the Stouffer Zscore scaled using the appropriate non-targeting null model (â€˜significanceZâ€™). To create
robust null models used to scale the statistical Z scores, we sample each non-targeting
guide up to 10 times each. For each experiment and number of guides per element, we
calculate the standard deviation of the null Stouffer Z scores. By dividing by this standard
deviation, we ensure that the null now has a standard deviation of 1, and so we can treat
them as a true Z scores, calculating P-values with the â€˜pnormâ€™ function. P-values can be
calculated with one-tail (up-/down-regulation) or two tails (either). FDRs are then
calculated per-experiment using the Benjamini-Hochberg procedure.
Synthetic data generation
For each simulation, we included 1,000 targeting guides (5 per element for 200 elements)
and 1,000 non-targeting guides designed to have no effect. The underlying abundance of
each guide (Ag) followed a Poisson distribution with mean 1,000 (representing library
construction noise; Ag ~ Pois(1000)). The number of cells sorted for each guide (Sg)
followed another Poisson distribution with a mean corresponding to the abundance of that
guide within the library (Sg ~ Pois(Ag)). For the mean-altering simulation (Fig. 2A,C),
expression levels of cells (Egc) were simulated by sampling from a normal distribution
with a mean corresponding to the assigned mean expression of that guide (Egc ~
Norm(Âµg)) for each sorted cell c. For the proportion-altering simulation (Fig. 2B,D), cells
were partitioned into responders and non-responders with a probability proportional to
the assigned fraction of cells whose expression is changed by the perturbation (rg), and
the expression followed a normal distribution with a mean 0 for non-responder cells and
1 for responder cells. The number of cells â€œsortedâ€ into each bin (Sbg) using the bounds of
each bin is:
!

ğ‘†!" =

ğ‘!! â‰¤ ğ¸!" â‰¤ ğ‘!!

Reads were simulated with a negative binomial distribution with the number of reads for
each bin equal to ten times the number of cells sorted into that bin and the probability of
selecting a guide equal to its fraction of cells within that bin (Fig. 2C):
!

ğ‘Ÿ!" ~ğ‘ğµ(10Ã—

ğ‘†!" ,

ğ‘†!"
!

ğ‘†!"

)

MAUDE, logFC, edgeR, and DESeq2 application to CD69 data
Raw count data for the CD69 CRISPRa screen was downloaded from PubMed Central
(Simeonov et al. Supplementary Table 1)9. The logFC values of the original analysis
14

bioRxiv preprint doi: https://doi.org/10.1101/819649; this version posted October 28, 2019. The copyright holder for this preprint (which was not
certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under
aCC-BY 4.0 International license.

were used as-is (â€œoriginalâ€). EdgeR (v 3.16.1) analysis was done with default parameters
by comparing high to baseline bins, for each of the two replicates, together, normalizing
the data (calcNormFactors) and performing a likelihood ratio test (estimateDisp, glmFit,
glmLRT), and the significance p-values and estimated log fold change retrieved
(topTags). DESeq2 (v 1.14.1) analysis was done with default parameters by creating a
DESeq2 experiment using the CD69 count data, comparing the high and baseline bins,
using both replicates (DESeqDataSetFromMatrix), and then comparing the expression
between these bins (using the â€œDESeqâ€ function). MAUDE analysis was performed with
default parameters on the count data for each bin, including the unsorted bin. We
estimated the fraction of cells in each bin for use in MAUDE analysis by reconstructing
the expression distribution in Simeonov et al. Extended Data Fig. 1a9 using the â€œdigitizeâ€
R package18, using the same data for both replicates. Using the actual bin proportions for
each replicate would likely increase MAUDEâ€™s performance.
For each evaluation criterion, we used effect sizes or significance values, as appropriate.
Effect sizes were: the mean of the two replicatesâ€™ guide Z-scores (MAUDE); the
estimated log fold change (edgeR and DESeq2); or the mean logFC for the two replicates
as originally reported (â€œoriginalâ€). Significance values were: combined replicatesâ€™ Z
scores by Stoufferâ€™s method (MAUDE); estimated p-values (edgeR and DESeq2); and
the mean of the two replicatesâ€™ logFCs (â€œoriginalâ€; no significance estimates were given
in Simeonov et al.).
For testing whether adjacent guides have similar effect sizes, we sorted the guides by the
genomic coordinates of the target site, and, for each pair of adjacent guides, calculated
the absolute difference in effect sizes. To create the random-pairing distribution, this was
repeated, including each guide 10 times (to improve our â€œrandomâ€ estimate), and
randomizing the order of the guides. The distributions in absolute effect size differences
between adjacent and randomly paired guides were compared with the Area Under the
ROC curve statistic (AUROC), and how much it differed from that expected by chance
(0.5; i.e. AUROC-0.5). Here, the AUROC is proportional to the fraction of randomly
paired guides whose absolute effect size differences are greater than those of adjacent
guides.
The AUROC statistic was also used to compare the guide significance distributions
between CD69 promoter-targeting guides and other genomic targeting guides, where the
AUROC is proportional to the fraction of promoter targeting guides that are more
significant than non-promoter targeting guides. Promoter-targeting guides were defined
as those in the 1 kb surrounding the CD69 TSS (between 9912997 and 9913996 on
chromosome 12; hg19).
For testing the correlation between replicates, the original logFC values and MAUDE
guide Z-scores were used directly.
Element-level statistics for CD69 screen were calculated with the sliding window
approach, using a 200 bp window and requiring a minimum of five guides per element.
To estimate the significance of the overlap between CD69-activating elements and Jurkat
open chromatin (DNaseI hypersensitivity), the distance distributions between open
chromatin sites and MAUDE-identified CD69-activating elements were compared for
actual vs. randomized open chromatin sites. The randomization placed open chromatin
15

bioRxiv preprint doi: https://doi.org/10.1101/819649; this version posted October 28, 2019. The copyright holder for this preprint (which was not
certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under
aCC-BY 4.0 International license.

elements in between the starts of the first and last open chromatin sites in the locus
(chr12: 9885788 â€“ 9973087), accepting only random placements with no overlap between
open chromatin sites, and preserving their widths. 100 such randomizations were created,
each time computing the distances between the MAUDE-identified CD69-upregulating
elements and the nearest randomly-placed open chromatin element. The distance
distributions for the actual open chromatin data vs. the randomized open chromatin data
were then compared using a two-tailed Wilcoxon rank sum test.

Abbreviations
AUROC: Area under the receiver operating characteristic curve
CaRE: CRISPRa responsive element (as identified in 9)
CRISPR: clustered regularly interspaced short palindromic repeats
FDR: false discovery rate
MAUDE: mean alterations using discrete expression
SD: standard deviation
TSS: transcription start site

Availability of data and software
All data analyzed during this study are included in the supplementary information of
Simeonov et al. (Supplementary Table 1) 9. MAUDE is available as an R package on
GitHub (https://github.com/Carldeboer/MAUDE).

Authors' contributions
CGD conceived of and implemented the algorithms with help from JPR. CGD drafted the
manuscript, with input from JPR, AR, and NH. All authors read and approved the final
manuscript.

Acknowledgements
We thank Benjamin Doughty and Charles Fulco for helpful discussions.
CGD was supported by a Fellowship from the Canadian Institutes for Health Research
and the NIH (K99-HG009920-01). JPR is funded by NIH 5 F32 AI129249. Work was
supported by the Klarman Cell Observatory and HHMI (AR), the Center for Cell
Circuits, a Center of Excellence in Genome Science (RM1HG006193), and the NHGRI
(R01HG008131-01; NH). NH is the David P. Ryan endowed chair, and thanks Sandra,
Sarah and Arthur Irving for support.
AR is an equity holder and founder of Celsius Therapeutics and an SAB member of
ThermoFisher Scientific, Neogene Therapeutics and Syros Pharmaceuticals. NH is a cofounder and equity holder of Neon Therapeutics. All other authors declare no competing
interests.

16

bioRxiv preprint doi: https://doi.org/10.1101/819649; this version posted October 28, 2019. The copyright holder for this preprint (which was not
certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under
aCC-BY 4.0 International license.

References
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.

17

Sanjana, N.E. et al. High-resolution interrogation of functional elements in
the noncoding genome. Science 353, 1545-1549 (2016).
Fulco, C.P. et al. Systematic mapping of functional enhancer-promoter
connections with CRISPR interference. Science 354, 769-773 (2016).
Gilbert, L.A. et al. CRISPR-mediated modular RNA-guided regulation of
transcription in eukaryotes. Cell 154, 442-451 (2013).
Konermann, S. et al. Genome-scale transcriptional activation by an
engineered CRISPR-Cas9 complex. Nature 517, 583-588 (2015).
Canver, M.C. et al. BCL11A enhancer dissection by Cas9-mediated in situ
saturating mutagenesis. Nature 527, 192-197 (2015).
Parnas, O. et al. A Genome-wide CRISPR Screen in Primary Immune
Cells to Dissect Regulatory Networks. Cell 162, 675-686 (2015).
Korkmaz, G. et al. Functional genetic screens for enhancer elements in
the human genome using CRISPR-Cas9. Nature biotechnology 34, 192198 (2016).
Fulco, C.P. et al. Activity-by-Contact model of enhancer specificity from
thousands of CRISPR perturbations. bioRxiv, 529990 (2019).
Simeonov, D.R. et al. Discovery of stimulation-responsive immune
enhancers with CRISPR activation. Nature 549, 111-115 (2017).
Robinson, M.D., McCarthy, D.J. & Smyth, G.K. edgeR: a Bioconductor
package for differential expression analysis of digital gene expression
data. Bioinformatics 26, 139-140 (2010).
Love, M.I., Huber, W. & Anders, S. Moderated estimation of fold change
and dispersion for RNA-seq data with DESeq2. Genome biology 15, 550
(2014).
Klann, T.S. et al. CRISPR-Cas9 epigenome editing enables highthroughput screening for functional regulatory elements in the human
genome. Nature biotechnology 35, 561-568 (2017).
Anders, S. & Huber, W. Differential expression analysis for sequence
count data. Genome biology 11, R106 (2010).
Trapnell, C. et al. Transcript assembly and quantification by RNA-Seq
reveals unannotated transcripts and isoform switching during cell
differentiation. Nature biotechnology 28, 511-515 (2010).
Hsu, J.Y. et al. CRISPR-SURF: discovering regulatory elements by
deconvolution of CRISPR tiling screen data. Nature methods 15, 992-993
(2018).
Sharon, E. et al. Inferring gene regulatory logic from high-throughput
measurements of thousands of systematically designed promoters. Nature
biotechnology 30, 521-530 (2012).
Maurano, M.T. et al. Systematic localization of common diseaseassociated variation in regulatory DNA. Science 337, 1190-1195 (2012).
Poisot, T. The digitize package: extracting numerical data from
scatterplots. The R Journal 3, 25-26 (2011).

